Pricing Log in Create free account

Bright Minds Biosciences Inc. (DRUG) vs Faeth Therapeutics, Inc. (FTH)

Bright Minds Biosciences Inc. and Faeth Therapeutics, Inc. are both Biotechnology companies. Bright Minds Biosciences Inc. and Faeth Therapeutics, Inc. are of similar size ($534.7M and $532.3M). Across the 8 metrics below, Bright Minds Biosciences Inc. leads on 5 and Faeth Therapeutics, Inc. on 3.

Valuation

Metric DRUG FTH Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.27 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.32 0.64
EV/Sales n/m n/m 9.21
Earnings yield (4.05%) (753.86%) (33.15%)
Free cash flow yield (3.52%) (31.94%) (25.50%)

Profitability

Metric DRUG FTH Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (13.64%) (195.26%) (56.36%)
Return on assets (13.52%) (176.88%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DRUG FTH Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (164.58%) 30.33% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRUG FTH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 121.98 19.69 4.72
Net debt to EBITDA 5.98 0.96 0.96

Dividend

Metric DRUG FTH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DRUG FTH Biotechnology median
Market cap 534.73m 532.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack